| Placebo group (n = 21) | FRG group (n = 21) | p- value2) | ||||
---|---|---|---|---|---|---|---|
 | Baseline | Week 4 | p- value1) | Baseline | Week 4 | p- value1) |  |
Fasting plasma glucose (mmol/l) | 6.4 ± 0.61 | 6.3 ± 0.6 | NS | 6.5 ± 0.5 | 6.1 ± 0.6 | 0.039 | NS |
Postprandial plasma glucose2h (mmol/l) | 9.0 ± 2.1 | 8.5 ± 1.9 | NS | 9.3 ± 2.2 | 7.7 ± 1.9 | 0.0001 | 0.008 |
AUCglucose (mmol/l) | 18.4 ± 0.7 | 17.3 ± 0.7 | 0.045 | 18.6 ± 0.7 | 13.5 ± 1.6 | 0.002 | 0.013 |
Fasting plasma insulin (μU/ml) | 7.4 ± 0.9 | 6.9 ± 0.6 | NS | 7.3 ± 1.0 | 9.0 ± 1.3 | NS | NS |
Postprandial plasma insulin2h (μU/ml) | 38.1 ± 3.9 | 35.5 ± 4.1 | NS | 39.2 ± 5.6 | 56.3 ± 9.8 | NS | 0.040 |